KFKenneth Färnqvist

Kenneth Färnqvist

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kenneth Färnqvist has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Rating Down for Publication Bias is Rare in Cochrane Reviews: A Descriptive Study

    by Markus Toews, Silvia Minozzi, Bernardine H. Stegeman, Michela Cinquini, Joerg J. Meerpohl, Kenneth Färnqvist, Matteo Bruschettini, Ingrid Toews

    Background: Publication bias impacts the direction and magnitude of summary effect estimates in systematic reviews and the confidence in the review findings. It remains unclear to what degree publication bias is considered in the certainty assessments in systematic reviews. Our research aims are to generate an overview of and estimate how frequent rating down occurs for the GRADE domain “publication bias” across Cochrane reviews. Study Design and Setting: This is a descriptive study. We included Cochrane reviews published between January 2021 and October 2023 that included at least one outcome for which the certainty of evidence was rated down for publication bias. We collected data from the reviews' full text, analyses, and figures. We analyzed data with descriptive statistical analysis. We used a deductive qualitative approach for analyzing qualitative data. Results: We identified 81 reviews. These reviews included between 1 and 328 individual studies. All but three reviews included randomized‐controlled trials only. Data from less than 10 studies supported the summary of findings of 106 outcomes. The most commonly used methods for detecting publication bias were funnel plots. 220 outcomes were rated down by one level for publication bias. Four outcomes were rated down by two levels. The most commonly reported reasons were indications of publication bias in funnel plots. Conclusions: Rating down for publication bias was rare in Cochrane reviews despite the high prevalence of publication bias in original research. Guidance might not suffice to inform assessments of publication bias in reviews with less than 10 studies.


  • Open Access

    Open Science Practices in Systematic Reviews From 2014 to 2024: A Cohort Study of 300 Systematic Reviews

    by Kenneth Färnqvist, Patrik Karlsson, Vera Wachtmeister, Patrick Vallance, Emma Sinervo

    Objectives: Open science practices, including the preregistration of protocols and the sharing of data and code, are increasingly promoted to enhance transparency, accessibility and the reuse of research outputs. However, systematic reviews, which are essential for informing clinical guidance and policy, often provide limited access to the materials needed for independent verification and reuse. Our objective was to estimate the prevalence of key open science indicators in interventional systematic reviews and to assess temporal changes by comparing our 2024 cohort with previously published cohorts from 2014 to 2020. Design: Cross‐sectional meta‐research study. Data Sources: MEDLINE, Embase, and CINAHL were searched in June 2024 for English‐language records indexed between 1 January and 1 February 2024. Eligibility Criteria: Interventional systematic reviews including human participants, a clearly defined PICO question, a systematic search strategy, a risk‐of‐bias assessment, and at least one meta‐analysis. Methods: Following our publicly registered protocol and STROBE guidance, records were randomly sampled and screened in duplicate until 300 eligible reviews were included. Data extraction was conducted in duplicate. We assessed protocol registration and availability, data sharing, code sharing, and preprint dissemination. Preprints were identified through extensive manual searches across more than 40 preprint servers and through author contact. Temporal changes were examined by comparing our 2024 cohort with previously published cohorts from 2014 to 2020 using pairwise risk ratios (RRs) with predefined equivalence ranges. Results: Among the 300 included reviews, cancer was the most common health condition (17%), and pharmacological or biological interventions were the most common intervention type (35%). The median number of primary studies included in each systematic review was 14 (IQR 9–23). Most reviews (73%) were published in journals with data and/or code‐sharing policies. In the 2024 cohort, 70% of systematic reviews reported a registered protocol or protocol availability and 61% included a data availability statement. However, only 24% shared underlying data, and analytical code was shared in 1% of reviews. Preprints were rare, occurring in 2% of the reviews. Reporting of protocol registration or availability increased substantially over time (2024 vs. 2014: RR 2.03, 95% CI 1.55–2.65; 2024 vs. 2020: RR 1.67, 95% CI 1.43–1.95), as did data availability statements (2024 vs. 2020: RR 1.98, 95% CI 1.63–2.40). Data sharing showed a nonlinear pattern, decreasing from 2014 to 2020 (RR 0.22, 95% CI 0.13–0.36) and increasing from 2020 to 2024 (RR 3.71, 95% CI 2.30–6.00), but remained uncommon overall. Code sharing was rare and showed no detectable change (OR 1.00, 95% CI 0.15–6.51). In the 2024 cohort, 3% of protocols were registered after manuscript submission. Conclusions: Several transparency indicators became more common over time, although trends differed across indicators. Yet the sharing of reusable research materials remains uncommon. Reusable data, analytic code, and preprints are rare outside the context of pandemics. These findings highlight a persistent gap between declarative openness and operational accessibility, emphasizing the necessity for more robust, verifiable mechanisms from journals and funders to reduce data distance and support independent verification and reuse of systematic review evidence. This gap between declared openness and practical accessibility continues to limit independent verification and reuse of systematic review evidence.

  • Open Access

    The architecture of survivorship : patterns of quality of life, symptom dynamics, and self- care in oesophageal and gastric cancer

    by Kenneth Färnqvist

    In recent decades, the survival rates of patients with oesophageal and gastric cancers have improved. However, many survivors continue to experience long- term symptoms and a diminished health-related quality of life (HRQL) even after treatment. Our understanding of the evolution of HRQL over time, variability in individual recovery, and management of persistent symptoms in daily life has improved, but gaps remain.The primary aim of this thesis was to explore patterns in HRQL, symptom dynamics, and self-care among patients with oesophageal and gastric cancer. It comprises five studies that employed systematic review and gap map analysis, as well as quantitative and mixed-method approaches. An evidence and gap map of the existing HRQL literature on oesophageal cancer systematically categorised and visualised the distribution and quality of research studies addressing various HRQL domains. Population-based longitudinal and cross- sectional analyses were conducted using two different cohorts of cancer survivors. One of the cross-sectional studies was complemented by qualitative interviews grounded in a critical realist framework.The findings suggest that survivorship following oesophageal and gastric cancer is characterised by a persistent symptom burden and considerable variability in recovery. Longitudinal analyses have identified distinct symptom trajectories among patients with oesophageal disease, indicating that average outcomes may obscure clinically significant variations. Moreover, sex and age correlated with differences in symptom burden and quality of life, indicating disparities in survivorship experiences.Self-care appears to be an important component in managing the long-term effects of the disease and treatment in cancer survivors. Although self-care engagement varied among cancer patients, those with high self-care engagement experienced a significantly better overall quality of life, and this relationship was influenced by educational level. Qualitative findings suggested that self-care practices were often maintained through routine, trust, and pragmatic adaptation rather than explicit causal reasoning.List of scientific papersI. Färnqvist K, Mälberg K, Johnsson SI, Johar A, Schandl A, Ringborg C, Lagergren P. Health-related quality of life in esophageal cancer: a state-of-the-art review of patient- reported outcomes and an evidence and gap map. Dis Esophagus. 2025 Sep 1;38(5):doaf086. https://doi.org/10.1093/dote/doaf086II. Färnqvist K, Mälberg K, Johar A, Schandl A, Lagergren P. Trajectories of patient-reported outcomes afteroesophageal cancer surgery - A population-based study. Eur J Cancer. 2024 Jul;206:114133. https://doi.org/10.1016/j.ejca.2024.114133III. Färnqvist K, Johar A, Schandl A, Lagergren P. Sex and age differences in longitudinal health-related quality of life: A population-based cohort study of oesophageal cancer survivors in Sweden. Eur J Surg Oncol. 2025 Nov 27;52(2):111302. https://doi.org/10.1016/j.ejso.2025.111302IV. Färnqvist K, Färnqvist S, Johar A, Schandl A, Lagergren P. Strategies and perceived mechanisms of self-care among individuals diagnosed and treated for oesophageal or gastric cancer: a sequential explanatory mixed-methods study. [Manuscript]V. Färnqvist K, Färnqvist S, Johar A, Schandl A, Lagergren P. Factors associated with Self-Care Engagement Among Oesophageal and Gastric Cancer Survivors: A Population- Based Cross-Sectional Study. [Manuscript]

  • Open Access

    The architecture of survivorship : patterns of quality of life, symptom dynamics, and self- care in oesophageal and gastric cancer

    by Kenneth Färnqvist

    In recent decades, the survival rates of patients with oesophageal and gastric cancers have improved. However, many survivors continue to experience long- term symptoms and a diminished health-related quality of life (HRQL) even after treatment. Our understanding of the evolution of HRQL over time, variability in individual recovery, and management of persistent symptoms in daily life has improved, but gaps remain.The primary aim of this thesis was to explore patterns in HRQL, symptom dynamics, and self-care among patients with oesophageal and gastric cancer. It comprises five studies that employed systematic review and gap map analysis, as well as quantitative and mixed-method approaches. An evidence and gap map of the existing HRQL literature on oesophageal cancer systematically categorised and visualised the distribution and quality of research studies addressing various HRQL domains. Population-based longitudinal and cross- sectional analyses were conducted using two different cohorts of cancer survivors. One of the cross-sectional studies was complemented by qualitative interviews grounded in a critical realist framework.The findings suggest that survivorship following oesophageal and gastric cancer is characterised by a persistent symptom burden and considerable variability in recovery. Longitudinal analyses have identified distinct symptom trajectories among patients with oesophageal disease, indicating that average outcomes may obscure clinically significant variations. Moreover, sex and age correlated with differences in symptom burden and quality of life, indicating disparities in survivorship experiences.Self-care appears to be an important component in managing the long-term effects of the disease and treatment in cancer survivors. Although self-care engagement varied among cancer patients, those with high self-care engagement experienced a significantly better overall quality of life, and this relationship was influenced by educational level. Qualitative findings suggested that self-care practices were often maintained through routine, trust, and pragmatic adaptation rather than explicit causal reasoning.List of scientific papersI. Färnqvist K, Mälberg K, Johnsson SI, Johar A, Schandl A, Ringborg C, Lagergren P. Health-related quality of life in esophageal cancer: a state-of-the-art review of patient- reported outcomes and an evidence and gap map. Dis Esophagus. 2025 Sep 1;38(5):doaf086. https://doi.org/10.1093/dote/doaf086II. Färnqvist K, Mälberg K, Johar A, Schandl A, Lagergren P. Trajectories of patient-reported outcomes afteroesophageal cancer surgery - A population-based study. Eur J Cancer. 2024 Jul;206:114133. https://doi.org/10.1016/j.ejca.2024.114133III. Färnqvist K, Johar A, Schandl A, Lagergren P. Sex and age differences in longitudinal health-related quality of life: A population-based cohort study of oesophageal cancer survivors in Sweden. Eur J Surg Oncol. 2025 Nov 27;52(2):111302. https://doi.org/10.1016/j.ejso.2025.111302IV. Färnqvist K, Färnqvist S, Johar A, Schandl A, Lagergren P. Strategies and perceived mechanisms of self-care among individuals diagnosed and treated for oesophageal or gastric cancer: a sequential explanatory mixed-methods study. [Manuscript]V. Färnqvist K, Färnqvist S, Johar A, Schandl A, Lagergren P. Factors associated with Self-Care Engagement Among Oesophageal and Gastric Cancer Survivors: A Population- Based Cross-Sectional Study. [Manuscript]

  • Open Access

    Transparency without reproducibility? Open science practices in systematic reviews from 2014 to 2024: a cohort study of 300 systematic reviews

    by Kenneth Färnqvist

    ObjectivesOpen science practices, including preregistration and sharing of data and code, aim to improve transparency and reproducibility. However, systematic reviews often remain difficult to replicate without access to underlying materials. We aimed to estimate the prevalence of key open science indicators in interventional systematic reviews and assess temporal changes by comparing a 2024 cohort with previously published cohorts from 2014 and 2020.DesignCross-sectional meta-research study.Data sourcesMEDLINE, Embase, and CINAHL were searched in June 2024 for English-language records indexed between 1 January and 1 February 2024.Eligibility criteriaInterventional systematic reviews with human participants, a clearly defined PICO question, a systematic search, risk-of-bias assessment, and at least one meta-analysis.MethodsFollowing a registered protocol and STROBE guidance, records were randomly sampled and screened in duplicate until 300 reviews were included. Data extraction was conducted in duplicate. We assessed protocol registration and availability, data sharing, code sharing, and preprint dissemination. Preprints were identified through manual searches across >40 servers and author contact. Temporal changes were analysed by comparing the 2024 cohort with 2014 and 2020 cohorts using pairwise risk ratios (RRs) with predefined equivalence ranges.ResultsAmong 300 reviews, cancer was the most common topic (17%), and pharmacological/biological interventions the most common type (35%). The median number of included studies was 14 (IQR 9–23). Most reviews (73%) were published in journals with data/code-sharing policies.In 2024, 70% reported a registered protocol and 61% included a data availability statement. However, only 24% shared underlying data and 1% shared analytical code. Preprints were rare (2%).Protocol registration increased over time (2024 vs 2014: RR 2.03, 95% CI 1.55 to 2.65; 2024 vs 2020: RR 1.67, 1.43 to 1.95), as did data availability statements (2024 vs 2020: RR 1.98, 1.63 to 2.40). Data sharing showed a nonlinear pattern, decreasing from 2014 to 2020 (RR 0.22, 0.13 to 0.36) and increasing from 2020 to 2024 (RR 3.71, 2.30 to 6.00), but remained uncommon. Code sharing showed no detectable change (OR 1.00, 0.15 to 6.51). In 2024, 3% of protocols were registered after submission.ConclusionsTransparency indicators have improved, yet materials required for reproducibility are rarely shared. Reusable data, analytic code, and preprints remain uncommon outside pandemics. These findings highlight a persistent gap between declared openness and practical accessibility, limiting independent verification and reuse of systematic review evidence and underscoring the need for stronger journal and funder requirements.

  • Open Access

    The Longevity of Mobile Apps for Cancer Recovery: Scoping Review

    by Kenneth Färnqvist, Luisa Thiele, Sophie Johnsson, Pernilla Lagergren, Anna Schandl

    Background: The number of cancer survivors is steadily increasing worldwide, leading to an increased demand for long-term follow-up and supportive care. Many survivors face ongoing physical and psychosocial issues that highlight the need for innovative management approaches. Mobile health apps offer potential benefits by facilitating patient-led follow-up, self-management, and more efficient use of health care resources. Although the market for cancer-related mobile apps has grown rapidly, their sustainability and scientific basis remain unclear. In the European Union, the Medical Device Regulation (MDR), in effect since May 2021, introduced stricter criteria for classifying medical devices, including certain software apps. While aiming to improve patient safety, the MDR could pose challenges for small companies and academic developers, potentially limiting the availability of such apps. No scoping review has delineated changes in active apps before and after implementation of the legislation regulating medical devices. Objective: This scoping review aimed to evaluate the current availability and longevity of English-language mobile apps supporting cancer recovery, with a specific focus on changes before and after the implementation of the European Union MDR, and to assess the extent to which these apps are supported by clinical evidence. Methods: Searches were conducted in mobile app stores (Apple’s App Store and Google Play) and literature databases (MEDLINE, Embase, Cochrane Library, and Web of Science), using predefined terms. Mobile apps targeting cancer recovery and published articles on their effectiveness were included. Two reviewers independently extracted data. A descriptive analysis was conducted to report trends in mobile device app availability and updates over time. Results: A total of 151 mobile apps were identified in 2018. However, by 2024, only 45 of 151 (30%) were still available. Among these, 25 of 151 (17%) were updated within the past 2 years. During the search in December 2024, 1 new mobile app supported by scientific evidence was discovered. This mobile app was developed to assist cancer survivors in managing insomnia through cognitive behavioral therapy. Rapid turnover and a potential lack of sustainability in the mobile health app market for cancer survivors were evident, with most mobile apps identified in 2018 no longer available by 2024. Conclusions: This review revealed a limited number of publicly available mobile apps that support cancer recovery. The longevity of existing mobile apps is limited, potentially because of regulatory and financial barriers. Prioritizing rigorous effectiveness trials, addressing implementation barriers, and developing sustainable business models are essential to ensure the long-term availability and success of mobile health apps in cancer survivorship care.

  • Open Access

    Assessing the feasibility and impact of clinical trial trustworthiness checks via an application to Cochrane Reviews: Stage 2 of the INSPECT-SR project

    by Jack Wilkinson, Calvin Heal, Georgios A. Antoniou, Ella Flemyng, Love Ahnström, Alessandra Alteri, Alison Avenell, Timothy Hugh Barker, David N. Borg, Nicholas J.L. Brown, et al.


  • Open Access

    Inclusion, characteristics and credibility of systematic reviews in doctoral theses: A cross-sectional study of all Medical Faculties in Sweden

    by Martin Ringsten, Kenneth Farnqvist, Matteo Bruschettini, Minna Johansson

    Objective: Systematic reviews (SRs) are essential to ensure that decisions are informed by an up-to-date and complete understanding of the relevant research evidence. Conducting SRs within a doctoral thesis can reduce redundant, harmful and unethical research, identify knowledge gaps, and help the doctoral student obtain important skills to conduct and use research. The output and learning process of SRs overlaps with the aims of doctoral programs. We aim to explore to what extent SRs are included in doctoral theses from all medical faculties in Sweden, and to describe the type, topic and assess the credibility of the reviews. Study design and setting: Duplicate assessors independently searched local and national repositories for doctoral theses published in 2021 within all seven medical faculties in Sweden, and categorized identified reviews based on review type, topic, and credibility using AMSTAR-2. Results: 5.4% (45/852) of all doctoral theses included a review, and 1.3% (45/3461) of all included studies were reviews. Of these, two thirds (31) were SRs and the rest (14) were broader ‘big picture’ reviews. The most common topics were interventions (42%) and exposure/etiology (32%), with no reviews of diagnostic tests. The majority of the SRs had very low (71%) or low (19%) credibility, and few reached a high (7%) or moderate (3%) credibility. The most common issues were limitations with protocols, limited search strategies, and failure to account for risk of bias in drawn conclusions. Conclusions: Few doctoral students included SRs in their theses, and the few SRs included in doctoral theses generally had a low credibility. Increasing the rate and quality of SRs in doctoral theses can help improve quality and relevance of subsequent primary research, and help students develop important skills. Actions are needed to support doctoral students to conduct high quality SRs. What is new?: Few doctoral students included systematic reviews (SRs) in their theses The few SRs included in doctoral theses generally had a low credibility Increasing the rate of SRs can help improve the relevance of subsequent research Moreover, to support development of important skills and reach educational goals Actions are needed to support doctoral students to conduct high quality SRs

  • Treating tendinopathies - are we searching for a needle in a haystack, when we should include the whole haystack?

    by Kenneth Färnqvist

    (2020). Treating tendinopathies – are we searching for a needle in a haystack, when we should include the whole haystack?. European Journal of Physiotherapy. Ahead of Print.